enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

   www.aol.com/news/novo-nordisk-discontinue...

   The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir, in response ...

3. Patients push back against Novo Nordisk move to scrap an ...

   www.aol.com/news/patients-push-back-against-novo...

   Novo reported U.S. Levemir sales of 1.3 billion Danish crowns ($185 million) in 2023, less than 10% of sales in 2016, when Novo launched the higher-priced Tresiba as a successor product.

4. Senate panel questions Novo Nordisk CEO over decision to ...

   www.aol.com/senate-panel-questions-novo-nordisk...

   The top of executive of Novo Nordisk told a Senate panel Tuesday it was a "difficult choice" to discontinue the long-acting insulin Levemir but he had to do so because of market forces.

5. Insulin detemir - Wikipedia

   en.wikipedia.org/wiki/Insulin_detemir

   Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]

6. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   In September 2022, Novo agreed to acquire Forma Therapeutics for $1.1 billion with the intent to expand its sickle cell disease and rare blood disorders portfolio. [32] By 2022 the popularity of Novo's Wegovy and Ozempic for weight loss was so great as to significantly increase growth of the entire economy of Denmark. Two-thirds of Denmark's ...

7. Category : Products and services discontinued in 2023

   en.wikipedia.org/wiki/Category:Products_and...

   Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more